Wellbutrin SR Patent Cases: Did GSK Surrender Claims To Excipients?

GlaxoSmithKline's patent infringement cases against Impax and Excel regarding Wellbutrin SR and Zyban appear to hinge on whether excipients used by the generic firms were "foreseeable.